{"id":"W4382987502","doi":"10.1111/pai.13982","title":"Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis","year":2023,"lang":"en","type":"article","venue":"Pediatric Allergy and Immunology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"Novartis Pharma","keywords":"Medicine; Placebo; Antihistamine; Pharmacokinetics; Internal medicine; Clinical trial; Potency; Randomized controlled trial; Quality of life (healthcare); Adverse effect; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008780792,0.000247899,0.001468751,0.002216366,0.00007631332,0.000008728925,0.0001329306,0.0003757309,0.00009725722],"category_scores_gemma":[0.0006316645,0.0001663618,0.0002463343,0.005910469,0.0004893685,0.00005268674,0.00005876178,0.0006670768,0.00002134156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005066339,"about_ca_system_score_gemma":0.0005684381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002072827,"about_ca_topic_score_gemma":0.0001106198,"domain_scores_codex":[0.9969023,0.0005233255,0.001311419,0.000508789,0.0002802368,0.0004738724],"domain_scores_gemma":[0.9982522,0.000640558,0.0004169338,0.0003540633,0.0001670993,0.000169211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9692539,0.002055925,0.006009995,0.00002564336,0.01804056,0.002674507,0.000201929,0.00007935942,0.0001182601,0.00003634381,0.00009491445,0.00140869],"study_design_scores_gemma":[0.9322655,0.005444015,0.03682417,0.00004893451,0.02073304,0.0003671271,0.00007286313,0.003883413,0.0000364178,0.00001810204,0.00008961192,0.0002168603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953179,0.002389185,0.0002810315,0.0004977413,0.0002111711,0.001030958,0.00001815379,0.0001040217,0.0001498355],"genre_scores_gemma":[0.9843354,0.0148334,0.00004573227,0.00003417183,0.000186599,0.00008503767,0.0002918373,0.0000235693,0.000164229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03698842,"threshold_uncertainty_score":0.6784037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0174243873227574,"score_gpt":0.3189940819229907,"score_spread":0.3015696946002333,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}